Literature DB >> 36029439

Probable sarcopenia: associations with common geriatric syndromes and comorbidities in Turkish geriatric patients from a university hospital.

Duygu Erbas Sacar1, Cihan Kılıc2, Meryem Merve Oren3, Tugba Erdogan2, Serdar Ozkok2, Caglar Ozer Aydın2, Nezahat Muge Catikkas2, Mehmet Akif Karan2, Gulistan Bahat2.   

Abstract

PURPOSE: EWGSOP2 defines "probable sarcopenia" as the presence of low muscle strength without non-muscle causes. The associations of probable sarcopenia have been studied in few reports to date, and our intention in this study is to identify associations of probable sarcopenia with common geriatric syndromes in a sample of older adults who attended the geriatric outpatient clinic of Istanbul University Hospital.
METHODS: The present study was designed as a retrospective cross-sectional study. We performed a comprehensive geriatric assessment to the participants. Univariate analyses were performed to determine relationship of probable sarcopenia with age, sex, common geriatric syndromes, i.e., frailty, falls, polypharmacy, malnutrition, and comorbidities, i.e., diabetes mellitus, hypertension, chronic kidney disease, chronic obstructive pulmonary disease (COPD), congestive heart failure (CHF), depression, osteoporosis, and the variables found to be significant were included in logistic regression analyses. The results are presented as an odds ratio (OR), with a 95% confidence interval (CI).
RESULTS: Included in the study were 456 participants with a mean age of 74.6 ± 6.6 years, of which 71.1% were female. Probable sarcopenia was identified in 12.7% (n = 58) of the sample. A multivariate analysis was carried out, the factors associated with probable sarcopenia were identified as male sex (OR 0.269, 95% CI 0.142-0.510), frailty (OR 4.265, 95% CI 2.200-8.267) and chronic kidney disease (OR 3.084, 95% CI 1.105-8.608).
CONCLUSION: Probable sarcopenia was more significantly associated with frailty than with other geriatric syndromes, signifying its importance as a marker for frailty. The study further identified chronic renal failure as a factor significantly associated with probable sarcopenia among the variety of studied diseases that frequently accompany aging.
© 2022. The Author(s), under exclusive licence to European Geriatric Medicine Society.

Entities:  

Keywords:  Comorbidity; Frailty; Probable sarcopenia; Sarcopenia

Year:  2022        PMID: 36029439     DOI: 10.1007/s41999-022-00691-9

Source DB:  PubMed          Journal:  Eur Geriatr Med        ISSN: 1878-7649            Impact factor:   3.269


  55 in total

Review 1.  Sarcopenia: an overview.

Authors:  Emanuele Marzetti; Riccardo Calvani; Matteo Tosato; Matteo Cesari; Mauro Di Bari; Antonio Cherubini; Agnese Collamati; Emanuela D'Angelo; Marco Pahor; Roberto Bernabei; Francesco Landi
Journal:  Aging Clin Exp Res       Date:  2017-02-02       Impact factor: 3.636

2.  Cut-off points for weight and body mass index adjusted bioimpedance analysis measurements of muscle mass.

Authors:  Gulistan Bahat; Asli Tufan; Cihan Kilic; Savaş Öztürk; Timur Selçuk Akpinar; Murat Kose; Nilgun Erten; Mehmet Akif Karan; Alfonso J Cruz-Jentoft
Journal:  Aging Clin Exp Res       Date:  2018-09-28       Impact factor: 3.636

3.  Gait speed and survival in older adults.

Authors:  Stephanie Studenski; Subashan Perera; Kushang Patel; Caterina Rosano; Kimberly Faulkner; Marco Inzitari; Jennifer Brach; Julie Chandler; Peggy Cawthon; Elizabeth Barrett Connor; Michael Nevitt; Marjolein Visser; Stephen Kritchevsky; Stefania Badinelli; Tamara Harris; Anne B Newman; Jane Cauley; Luigi Ferrucci; Jack Guralnik
Journal:  JAMA       Date:  2011-01-05       Impact factor: 56.272

4.  Sarcopenia and mortality among older nursing home residents.

Authors:  Francesco Landi; Rosa Liperoti; Domenico Fusco; Simona Mastropaolo; Davide Quattrociocchi; Anna Proia; Matteo Tosato; Roberto Bernabei; Graziano Onder
Journal:  J Am Med Dir Assoc       Date:  2012-02       Impact factor: 4.669

5.  Sarcopenia as a Risk Factor for Future Hip Fracture: A Meta-Analysis of Prospective Cohort Studies.

Authors:  P Huang; K Luo; J Xu; W Huang; W Yin; M Xiao; Y Wang; M Ding; X Huang
Journal:  J Nutr Health Aging       Date:  2021       Impact factor: 4.075

6.  Association of different bioimpedanciometry estimations of muscle mass with functional measures.

Authors:  Gulistan Bahat; Cihan Kilic; Birkan Ilhan; Mehmet A Karan; Alfonso Cruz-Jentoft
Journal:  Geriatr Gerontol Int       Date:  2019-04-21       Impact factor: 2.730

7.  Sarcopenia: European consensus on definition and diagnosis: Report of the European Working Group on Sarcopenia in Older People.

Authors:  Alfonso J Cruz-Jentoft; Jean Pierre Baeyens; Jürgen M Bauer; Yves Boirie; Tommy Cederholm; Francesco Landi; Finbarr C Martin; Jean-Pierre Michel; Yves Rolland; Stéphane M Schneider; Eva Topinková; Maurits Vandewoude; Mauro Zamboni
Journal:  Age Ageing       Date:  2010-04-13       Impact factor: 10.668

8.  Cut-off points for height, weight and body mass index adjusted bioimpedance analysis measurements of muscle mass with use of different threshold definitions.

Authors:  Gulistan Bahat; Asli Tufan; Cihan Kilic; Tugba Aydın; Timur Selçuk Akpinar; Murat Kose; Nilgun Erten; Mehmet Akif Karan; Alfonso J Cruz-Jentoft
Journal:  Aging Male       Date:  2018-09-29       Impact factor: 5.892

Review 9.  Health Outcomes of Sarcopenia: A Systematic Review and Meta-Analysis.

Authors:  Charlotte Beaudart; Myriam Zaaria; Françoise Pasleau; Jean-Yves Reginster; Olivier Bruyère
Journal:  PLoS One       Date:  2017-01-17       Impact factor: 3.240

10.  Sarcopenia: revised European consensus on definition and diagnosis.

Authors:  Alfonso J Cruz-Jentoft; Gülistan Bahat; Jürgen Bauer; Yves Boirie; Olivier Bruyère; Tommy Cederholm; Cyrus Cooper; Francesco Landi; Yves Rolland; Avan Aihie Sayer; Stéphane M Schneider; Cornel C Sieber; Eva Topinkova; Maurits Vandewoude; Marjolein Visser; Mauro Zamboni
Journal:  Age Ageing       Date:  2019-01-01       Impact factor: 10.668

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.